Psilocybin-Assisted Psychotherapy: Treating Depression and Anxiety with Mushrooms
OpenAlex – August 05, 2020
Source: OpenAlex
Summary
A single dose profoundly affecting mental health for months could revolutionize psychiatry. Emerging drug studies suggest psilocybin, a synthesized alkaloid, offers sustained relief from debilitating anxiety and depression, conditions affecting over 20% of adults and imposing significant economic burdens. This innovative medicine, delivered by a psychotherapist, represents a paradigm shift in psychology. Unlike traditional daily pharmaceuticals, these psychedelics could offer a more effective, long-lasting solution to mental health challenges.
Abstract
Depression and anxiety are debilitating mental health conditions that affect a large portion of the United States. Current pharmacological treatments for these disorders require daily administration, are associated with a number of side effects, and can be ineffective for some. Emerging evidence in novel treatment options may necessitate a shift toward how we treat these psychiatric disorders.